116 related articles for article (PubMed ID: 11154993)
1. Clinical usefulness of combined measurements of serum soluble transferrin receptor levels and serum interleukin-18 levels at determination of serum KL-6 levels in haematologic malignancies.
Takubo T; Kumura T; Nakao T; Nakamae H; Aoyama Y; Nishiki S; Kinoshita Y; Koh KR; Ohta K; Yamane T; Hino M; Kamitani T; Tatsumi N
Acta Haematol; 2000; 104(2-3):141-3. PubMed ID: 11154993
[No Abstract] [Full Text] [Related]
2. Lymphoma in Castleman's disease, acute lymphocytic leukemia, adult T-cell leukemia and cutaneous T-cell lymphoma accompanied with high serum soluble Fas ligand levels.
Takubo T; Ohkura H; Kumura T; Ohta K; Yamane T; Hino M; Kamitani T; Tatsumi N
Haematologia (Budap); 2000; 30(1):23-6. PubMed ID: 10841320
[No Abstract] [Full Text] [Related]
3. Clinical significance of simultaneous determination of serum soluble transferrin receptor, soluble Fas, soluble Fas ligand, hepatocyte growth factor and interleukin 18 levels in a patient with hemophagocytic syndrome.
Takubo T; Kumura T; Nishiki S; Kinoshita Y; Koh K; Ohta K; Yamane T; Hino M; Kamitani T; Tatsumi N
Acta Haematol; 2000; 103(3):165-7. PubMed ID: 10940656
[No Abstract] [Full Text] [Related]
4. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
[TBL] [Abstract][Full Text] [Related]
5. Serum KL-6 levels in haematologic malignancies and their clinical application.
Takubo T; Kumura T; Nakao T; Nakamae H; Aoyama Y; Nishiki S; Kinoshita Y; Koh KR; Ohta K; Yamane T; Hino M; Kamitani T; Tatsumi N
Haematologia (Budap); 2001; 31(1):61-7. PubMed ID: 11345406
[No Abstract] [Full Text] [Related]
6. Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients?
Dincaslan HU; Yavuz G; Unal E; Tacyildiz N; Ikinciogullari A; Dogu F; Guloglu D; Yuksek N; Ertem U
Pediatr Hematol Oncol; 2010 Oct; 27(7):503-16. PubMed ID: 20677920
[TBL] [Abstract][Full Text] [Related]
7. [The serum levels of soluble interleukin-2 receptor in patients with malignant lymphocytic proliferative disorders].
Xu J; Wang B
Zhonghua Xue Ye Xue Za Zhi; 1998 Feb; 19(2):82-4. PubMed ID: 10921108
[TBL] [Abstract][Full Text] [Related]
8. KL-6: marker for pulmonary involvement in Langerhans cell histiocytosis in infants.
Matsubayashi T; Miwa Y; Saito I; Matsubayashi R
J Pediatr Hematol Oncol; 2004 Sep; 26(9):584-6. PubMed ID: 15342985
[TBL] [Abstract][Full Text] [Related]
9. Bronchoalveolar lavage is a safe and informative procedure in haematologic patients with nonresolving pneumonia.
Lindhart Pedersen T; Pedersen M; Myhre J; Milman N; Johnsen H
Eur J Haematol; 1992 Nov; 49(5):280-1. PubMed ID: 1473592
[No Abstract] [Full Text] [Related]
10. Elevation of serum KL-6 levels in patients with hematological malignancies associated with cytomegalovirus or Pneumocystis carinii pneumonia.
Tanaka M; Tanaka K; Fukahori S; Fujimatsu Y; Jojima H; Shiraishi K; Honda J; Oizumi K
Hematology; 2002 Apr; 7(2):105-8. PubMed ID: 12186700
[TBL] [Abstract][Full Text] [Related]
11. Expression of KL-6 antigen on leukemia cells of a patient with chronic myelocytic leukemia in blastic phase.
Takubo T; Fujino H; Hino M; Yamane T; Ohta K; Koh KR; Kumura T; Hashimoto S; Nakao T; Nakamae H; Aoyama Y; Nishiki S; Kinoshita Y; Kamitani T; Tatsumi N; Hojo S; Fujita J
Haematologia (Budap); 2001; 31(2):173-6. PubMed ID: 11583030
[No Abstract] [Full Text] [Related]
12. The fibrinolytic enzyme system in haematological malignancy.
Dawson AA; Ogston D; Douglas AS
Bibl Anat; 1973; 12():272-8. PubMed ID: 4597632
[No Abstract] [Full Text] [Related]
13. [Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia].
Kohno N
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():186-9. PubMed ID: 9216213
[TBL] [Abstract][Full Text] [Related]
14. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects.
Paydas S; Tanriverdi K; Yavuz S; Disel U; Baslamisli F; Burgut R
Am J Hematol; 2005 Aug; 79(4):257-61. PubMed ID: 16044453
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma.
Hentschel N; Krusch M; Kiener PA; Kolb HJ; Salih HR; Schmetzer HM
Eur J Haematol; 2006 Aug; 77(2):91-101. PubMed ID: 16800841
[TBL] [Abstract][Full Text] [Related]
16. [Erythroid antigens in children with hemoblastoses].
Tupitsyn NN; Drozdova TS; Protasova AK; Kiselev AV; Baryshnikov AIu
Sov Med; 1988; (7):29-32. PubMed ID: 3227449
[No Abstract] [Full Text] [Related]
17. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
[TBL] [Abstract][Full Text] [Related]
18. Levels of serum and cerebrospinal fluid soluble CD27 in the diagnosis of leptomeningeal involvement of hematolymphoid malignancies.
Kara IO; Sahin B; Gunesacar R
Adv Ther; 2007; 24(4):741-7. PubMed ID: 17901023
[TBL] [Abstract][Full Text] [Related]
19. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
[TBL] [Abstract][Full Text] [Related]
20. Serum Ca 125 levels in children with acute leukemia and lymphoma.
Birgen D; Ertem U; Duru F; Sahin G; Yüksek N; Bozkurt C; Karacan CD; Aksoy C
Leuk Lymphoma; 2005 Aug; 46(8):1177-81. PubMed ID: 16085559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
